Search

How reliable is non-echoplanar diffusion-weighted MRI in picking up postoperative cholesteatoma in children?

Cholesteatoma occurs more often in children than in adults and is more aggressive, often resulting in ossicular erosion and marked conductive loss, amongst other more serious possibilities. Recurrence happens in all three methods used, namely canal wall up, canal wall...

Choosing instrumental assessments of swallowing for children

Swallowing disorders in children are increasingly common due to advances in medical care allowing them to survive prematurity or complex health conditions. Careful assessment of eating and drinking is necessary to ensure that children are managed both safely and with...

COVID-19 and dysphagia in critically ill patients: a reflection of some findings

Dysphagia was a common occurrence in patients admitted to intensive care units (ITU) during the pandemic. This paper explores data from 26 ITUs over 12 months during 2020-2021. Findings from 235 patients admitted with Delta and subsequent Covid variants who...

How rare is vocal fold paralysis after spinal and epidural anaesthesia – should we be more concerned?

The authors present an unusual case of right vocal fold paralysis. Their patient was a 38-year-old woman who experienced new onset dysphonia following neuraxial anaesthesia (NA) for a caesarean section. Flexible nasendoscopy showed a right VFP with fixation in the...

Do easier-to-swallow tablets improve medication adherence in people with dysphagia?

Swallowing tablets can be challenging for many people, but particularly so for those with a diagnosis of dysphagia. As a result, many medications are prepared in alternate formats including liquid, dissolvable or orally disintegrating tablets that dissolve on contact with...

Canal cholesteatoma

This is a retrospective study of patients with external auditory canal cholesteatoma (EACC) managed at a single tertiary centre from 1 January 2010 to 1 January 2021. Ninety patients (100 ears) were included. Mean age at diagnosis was 56+23 years....

Eosinophilic complications during dupilumab therapy

Dupilumab is a humanised monoclonal antibody that targets type 2 inflammation by blocking IL-4 and IL-13 signalling. Reported adverse events from its use include injection site erythema, conjunctivitis, arthralgia and hypereosinophilia. The potential for more severe eosinophilic-related complications such as...